Morepen Labs. (MOREPENLAB)

STALWART

FairStock Score: 18/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Current Price₹42.69
Market Cap₹2,392.91 Cr
P/E Ratio31.34
ROCE15.08%
ROE5.04%
Dividend Yield0.46%
Profit Growth3.07%
Debt/Equity0.13
Sales Growth6.93%
Promoter Holding35.65%
52-Week Range₹33.05 — ₹70.5
SectorPharmaceuticals & Biotechnology
Book Value₹21.16

Morepen Labs. trades with a P/E ratio of 31.34, ROCE of 15.08%, ROE of 5.04%, profit growth of 3.07%, debt-to-equity of 0.13. The FairStock Score of 18/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer